4.8 Article

Depletion of fat-resident Treg cells prevents age-associated insulin resistance

Journal

NATURE
Volume 528, Issue 7580, Pages 137-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature16151

Keywords

-

Funding

  1. National Institutes of Health (NIH) [F30 DK096828, T32 GM007198]
  2. National Health and Medical Research Council of Australia [512354, 632886, 1043199]
  3. NIH [DK057978, DK090962, HL088093, HL105278, ES010337]
  4. Glenn Foundation for Medical Research
  5. Leona M. and Harry B. Helmsley Charitable Trust
  6. Ipsen/Biomeasure
  7. California Institute for Regenerative Medicine
  8. Ellison Medical Foundation
  9. Nomis Foundation
  10. Rita Allen Foundation
  11. Emerald Foundation
  12. Hearst Foundation
  13. National Multiple Sclerosis Society
  14. National Institutes of Health [AI099295, AI107027]
  15. National Cancer Institute [CA014195]
  16. James B. Pendleton Charitable Trust

Ask authors/readers for more resources

Age-associated insulin resistance (IR) and obesity-associated IR are two physiologically distinct forms of adult-onset diabetes. While macrophage-driven inflammation is a core driver of obesity-associated IR1-6, the underlying mechanisms of the obesity-independent yet highly prevalent age-associated IR7 are largely unexplored. Here we show, using comparative adipo-immune profiling in mice, that fat-resident regulatory T cells, termed fT(reg) cells, accumulate in adipose tissue as a function of age, but not obesity. Supporting the existence of two distinct mechanisms underlying IR, mice deficient in fT(reg) cells are protected against age-associated IR, yet remain susceptible to obesity-associated IR and metabolic disease. By contrast, selective depletion of fT(reg) cells via anti-ST2 antibody treatment increases adipose tissue insulin sensitivity. These findings establish that distinct immune cell populations within adipose tissue underlie ageing- and obesity-associated IR, and implicate fT(reg) cells as adipo-immune drivers and potential therapeutic targets in the treatment of age-associated IR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available